Pfizer’s Medical & Academic Partnerships (MAP) Program supports the career development of healthcare professionals and researchers dedicated to improving the health and lives of patients through direct patient care and/or conducting clinical or epidemiologic research. Since its inception in 1984, MAP has proudly funded more than 1,000 research and medical education endeavors.
Currently, Pfizer’s External Medical Affairs (EMA), US Medical Affairs (Rheumatology) and Independent Grants for Learning and Change (IGLC) organizations are providing support for fellowships and visiting professorships in the rheumatology therapeutic area.
Pfizer remains committed to supporting and advancing research, innovation, and medical education for academic centers and schools of medicine, nursing, osteopathic medicine, pharmacy, and public health. Through Public-Private Partnerships, Pfizer continues to map-a-course of discovery for a wide variety of clinical and population health issues, with the goal of finding innovative ways to promote healthy lifestyles and prevent and treat acute and chronic disease. Partnerships with organizations such as the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) help develop future medical leaders and drive advances in patient care.